Skip to main content
. 2019 Nov 27;11(12):1882. doi: 10.3390/cancers11121882

Table 1.

Studies addressing exposures to chemicals and risk of breast cancer according to hormone receptor status.

References Country (Period of Investigation) Occupational Chemical Exposure; Job Tasks Investigated Population Methods Results
Petralia et al. [13] USA
(1986–1991)
Benzene and PAHs
PAH exposure (no benzene): traffic, shipping and receiving clerks, inspectors, testers, graders in motor vehicles industry
Benzene exposure (no PAH): laboratory technologists and technicians, painters, sculptors, artists, assemblers in motor vehicle industry
PAH and benzene: bus truck and stationary engine mechanics, molding and casting machine operators, garage, and service station occupation
Women with premenopausal breast cancer (age: ≥40 years) (n.301)
Referents matched by age and country of residence (n.316)
  • Tumors with ER >10 fmol/mg or cells with ER > 10% classified as ER-positive.

  • Personal, medical, and occupational histories obtained by interviews.

  • Exposure assessed by job-exposure matrices

  • Overall breast cancer risk increased with ever being exposed to chemicals. Benzene (possible PAH co-exposure) (OR: 1.91; 95%CI 1.18–3.08); PAH (possible benzene co-exposure) (OR: 1.82; 95%CI 1.02–3.16); PAH and benzene -all exposed groups (OR: 2.01; 95%CI 1.08–3.75); exclusively benzene (OR: 1.70; 95%CI 1.17–2.92)

  • No increased overall breast cancer risk following exposure to PAH alone (OR: 1.01; 95%CI 0.55–3.45)

  • Increased risk of ER-positive cases in all exposure, except benzene alone: PAH (possible benzene co-exposure) (OR: 2.27; 95%CI 1.14–4.54); Benzene (possible PAH co-exposure) (OR: 2.29; 95%CI 1.27–4.13), PAH and benzene (OR: 2.54; 95%CI 1.28–5.04); Exclusively benzene (OR: 1.74; 95%CI 0.72–4.21).

  • No increased risk for ER-positive tumors for PAH exposure alone (OR: 0.78; 95%CI 0.12–5.03)

  • ER-negative cases: PAH (possible benzene co-exposure) (OR: 1.12; 95%CI 0.47–2.64); Benzene (possible PAH co-exposure) (OR: 1.49; 95%CI 0.74–3.02), exclusively PAH (OR: 1.79; 0.46–8.52); PAH and benzene (OR: 1.28; 95%CI 0.52–3.15); Exclusively benzene (OR: 2.10; 95%CI 0.87–5.53).

Labreche et al. [14] Canada
(1996–1997)
Organic solvents in broad categories
Organic solvents: gasoline, diesel, jet fuel engine emissions and mineral spirits
Monoaromatic hydrocarbons: benzene, toluene, xylene, and styrene
Compounds containing PAH from petroleum: carbon black, petroleum soot, jet fuel engine emissions, oil-based cutting fluids and more
Other chemicals: wool, acrylic and rayon fibers
Women with postmenopausal primary breast (n.556; 50–75 years old)
Women with other cancers matched by age (n.613)
  • Personal, medical, and occupational histories obtained by interviews.

  • Exposure assessed translating all jobs into a set of exposure indices by a team of experienced industrial hygienists and chemists

  • Hormonal receptor status categorized as positive or negative for ER and/or PR, as provided in the pathology reports.

  • No significant alterations in risk of postmenopausal breast cancer with lifetime (OR: 1.14; 95%CI 0.80–1.62), or early (<36 years) exposure to organic solvents (OR: 1.30; 95%CI 0.65–2.60).

  • Organic solvents increased the risk for ER-positive/PR-negative tumors in early exposures (<36 years) (OR: 3.31; 95%CI 1.07–10.20)

  • PAHs from petroleum associated with increased risk of ER-positive/PR-positive tumors for both lifetime (OR: 1.65; 95%CI 0.97–2.83) and early (OR: 3.00; 95%CI 1.10–8.13) exposure.

  • Acrylic fibers: For ER-positive/PR-negative tumors the risk tripled for each 10-year increase in duration on exposure to organic solvents and more than doubled for each 10-year increase in duration of exposure to monoaromatic hydrocarbons. Exposure to PAHs from petroleum tripled the risk for ER-positive/PR-positive tumors.

Peplonska et al. [15] Poland
(2000–2003)
Organic solvents and benzene
“Organic solvents” include aromatic, aliphatic, chlorinated hydrocarbons, ketones, organic acid esters, petroleum distillates.
Female newly diagnosed with in situ or invasive breast cancer (n.2383; age: 20–74 years)
Controls matched to the cases by city of residence and age (n.2502).
  • Personal, medical, and occupational histories obtained by questionnaires, medical records, and pathology forms.

  • Occupational exposure scored as intensity, probability, and duration.

  • ER and PR status determined by immunohistochemistry or biochemical methods.

  • Non-significant increase in breast cancer risk in women ever exposed to organic solvents (OR: 1.16; 95%CI 0.99–1.4). No significant changes for benzene exposure alone (OR: 1.00; 95%CI 0.8–1.3)

  • None of the exposure metrics showed evidence for a exposure-response risk of breast cancer.

  • Exposure to organic solvents significantly associated with an increased risk for negative ER and PR tumors (OR 1.40; 95%CI 1.1–1.8).

Ekenga et al. [16] USA and Puerto Rico
(2003–2009)
Solvent exposed occupations
Building and grounds cleaning and maintenance; education, training, and library; food preparation and serving related; healthcare practitioner and technical; management; office administrative and support; production occupations.
Women enrolled in the Sister Study (n. 47,661 sisters of women with breast cancer) occupationally exposed to solvents
Women diagnosed with breast cancer during follow-up (n. 1798)
  • Personal, medical, and occupational histories obtained by interviews and questionnaires.

  • Most commonly reported solvent-exposed occupations classified into major categories.

  • Data on receptor status obtained by medical record, pathology report data or self-reported.

  • No increased risk of invasive breast cancer among women occupationally exposed to solvents (HR: 1.04; 95%CI 0.88–1.24).

  • Non-significant increase for ER-positive tumors in exposed women (HR: 1.15; 95%CI 0.95–1.39)

  • ER-positive tumors significantly associated with exposure before the birth of their first child (HR 1.39; 95% CI 1.03–1.86) and first exposure to solvents occurred before 1980 (HR: 1.28; 95%CI 1.01–1.62).

  • Significantly elevated risk for ER-positive cancers associated in clinical laboratory technologists and technicians who worked with solvents (HR: 2.00, 95%CI: 1.07–3.73)

Glass et al. [17] Australia
(2009–2011)
Solvents
Benzene, other aromatic, aliphatic, chlorinated solvents, and alcohol
Women with first incident invasive primary breast cancer (n.1205; aged 18–80 years)
Randomly selected age-matched controls (n.1789)
  • Personal, medical, and occupational histories obtained by interviews and questionnaires.

  • Occupational solvents exposure assessed using telephone interview and the web-based application OccIDEAS.

  • Information on ER status obtained by interviews and questionnaires.

  • Non-significant increase in the risk of breast cancer among women professionally exposed to aliphatic (OR 1.21; 95% CI 0.99-1.48) and aromatic (OR 1.21; 95% CI 0.97–1.52) solvents

  • No differences detected for hormonal receptor status.

Lee et al. [18] Canada
(2005–2010)
Polycyclic aromatic hydrocarbons
Food-service industry (>20%)
Women aged 40–80 years diagnosed with in situ or invasive breast cancer (n.1130).
Women recruited from the Breast Screening Programme as age-matched controls (n.1169)
  • Personal, medical, and occupational histories obtained with questionnaires

  • Exposure to PAHs assessed by a job exposure matrix based on a statistical model

  • Exposure to any level of PAHs associated with a significantly increased risk of breast cancer (OR: 1.32, 95%CI 1.10–1.59)

  • Evidence of increased risk with duration of exposure apparent for medium or high exposure levels (the longest duration: OR: 1.41, 95%CI: 1.10–1.81) and high exposure levels (the longest duration: OR: 1.45, 95%CI: 1.10–1.91).

  • No difference in breast cancer risk observed by receptor status

Lerro et al. [19] USA
(Enrollment: 1993–1997; Follow-up: until 2010–2011)
Organophosphate (OP) insecticides
OP insecticides: chlorpyrifos, coumaphos, diazinon, dichlorvos, fonofos, malathion, parathion, phorate, terbufos, trichlorfon
Spouses of private pesticide applicators (n. 30,003)
Women with diagnosed breast cancer during the follow up period (n. 718)
  • Personal, medical, and occupational histories obtained by questionnaires.

  • Pesticides exposure assessed by questionnaires

  • Incident breast cancer cases ascertained through population-based cancer registries.

  • Any OP use associated with an elevated risk of breast cancer (RR: 1.20, 95%CI 1.01–1.43)

  • Chlorpyrifos use (RR: 1.41, 95% CI: 1.00–1.99) and terbufos use (RR: 1.52; 95% CI 0.97–2.36) associated with non-significantly elevated risk of breast cancer

  • Among post-menopausal women, significantly elevated risk of breast cancer associated with use of any OP (RR: 1.27, 95%CI 1.00–1.62), and non-significantly elevated breast cancer risk associated with chlorpyrifos (RR: 1.53, 95%CI 0.96–2.44) and terbufos (RR: 1.73; 95%CI 0.93–3.21).

  • Chlorpyrifos was associated with a significantly increased risk of ER-negative/PR-negative breast cancer (RR: 2.26, 95% CI: 1.07–4.75)

Engel et al. [20] USA
(Enrollment: 1993–1997; Follow-up: until 2010–2011)
OP insecticides Spouses of private pesticide applicators (n.30594)
Women with diagnosed incident breast cancer during follow-up period (n.1081)
  • Personal, medical, and occupational histories obtained by questionnaires and interviews.

  • Pesticides exposure assessed by questionnaires

  • Incident breast cancer cases ascertained through population-based cancer registries.

  • Ever personal use of any insecticide associated with risk of breast cancer (HR: 1.0; 95%CI 0.7–2.9)

  • Significant association between breast cancer risk and ever use of chlorpyrifos (HR: 1.4, 95%CI: 1.0–2.0) and terbufos (HR: 1.5, 95% CI: 1.0–2.1).

  • No significant differences in risk related to the woman’s use of insecticides according to ER tumoral status.

Rabstein et al. [21] Germany
(2000–2004)
Aromatic and heterocyclic amines (AHA)
Job activities: developing of films, rubber industry, using dyes, painting, working with tar.
Incident breast cancer cases from the GENICA study, a German population-based case-control study (n.1155)
Age-matched controls (n.1143)
  • Data on breast cancer risk factors obtained with interviews.

  • Expert rating applied to assess possible occupational exposure based on self-assessed tasks.

  • Immunohistochemical staining of breast-cancer tissues: ER+ and PR+ when ≥10% cells showed nuclear staining.

  • No significant association for occupational AHA exposure and risk of overall breast cancer (OR: 1.05; 95%CI 0.70–1.56 for >1-year exposure vs. none or < 1 year).

  • No significant association for occupational AHA exposure and risk of ER-positive (OR: 1.26; 95%CI 0.81–1.95 for >1 year exposure vs. none or < 1 year) or ER-negative cancers (OR: 0.81; 95%CI 0.36–1.82 for >1 year exposure vs. none or < 1 year)

  • No significant association for occupational AHA exposure and risk of PR-positive (OR: 1.24; 95%CI 0.79–1.94 for >1 year exposure vs. none or < 1 year) or PR-negative cancers (OR: 0.82; 95%CI 0.38–1.76 for >1 year exposure vs. none or < 1 year)

Ekenga et al. [22] USA and Puerto Rico
(2003–2009)
Different chemical substances
Acids, dyes or inks, gasoline or other petroleum products, glues, or adhesives, lubricating oils, metals, paints, pesticides, soldering materials, solvents and stains or varnishes.
Women enrolled in the Sister Study (n. 45,674 sisters of women with breast cancer) occupationally exposed to different chemicals
Women diagnosed with breast cancer during follow-up (n. 1966)
  • Personal, medical, and occupational histories obtained by interviews and questionnaires.

  • Cumulative exposure to each agent estimated as a function of frequency and duration of use; quartile cut points were used to assign participants to exposure categories

  • Data on receptor status obtained by medical record, pathology report data, or self-reported.

  • No significant associations between ever use of chemical agents and breast cancer risk.

  • Significant association between occupational exposure to soldering materials and premenopausal breast cancer (HR: 1.8, 95%CI = 1.1–3.0).

  • Women with cumulative exposure to gasoline or petroleum products ≥ the highest quartile cutoff had an elevated risk of total (HR: 2.3, 95% CI: 1.1–4.9) and invasive (HR: 2.5, 95% CI: 1.1–5.9) breast cancer compared with women in the lowest quartile.

  • Risk estimates did not differ significantly by hormone receptor status.

  • Exposure to gasoline or other petroleum products in the highest quartile associated with a non-significant increased risk of hormone-receptor positive breast cancer (Q4 vs. never used: HR: 1.4, 95% CI: 0.9–2.3; Q4 vs. Q1: HR: 2.5, 95% CI: 1.0–5.8).

  • Borderline increased risk of hormone receptor-positive cancer observed for women in the highest quartile of exposure to paints (Q4 vs. never used: HR: 1.4, 95% CI: 1.0–2.0).